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Abstract
Objectives The aim of this study was to examine the risk of bladder cancer according to the trajectory pattern of amount of 
smoking among Korean young adult men.
Methods Smoking status was assessed with a standardized questionnaire in the Korean Life Course Health Study (KLCHS). 
Trajectory analyses were performed among young adult men using seven repeated surveys of cigarette per day (CPD) every 
two years from 1992 to 2005. The occurrence of bladder cancer was tracked from 2006 to 2016. The Cox proportional models 
were used to calculate the hazard ratio (HR) (95% confidence interval) of smoking patterns on bladder cancer.
Results The mean (standard deviation) age of the 161,069 participants was 34.0 (3.9) years, and 2,280,143 person-years 
(PY) were examined during the follow-up period of 14.2 (median 14.3) years. During this period, 263 new cases of bladder 
cancer occurred (11.5/100,000 PY). Among the six trajectory groups (low steady, lowering, rise and fall, high steady, rise 
and sharp fall, and very high steady), there was a higher risk of developing bladder cancer in the all the other groups com-
pared to the low steady group. The highest risk group was the very high steady group, with HR 2.83 (95% CI 1.79–4.49). In 
addition, the risk of bladder cancer was 2.61 (95% CI 1.50–4.54) in the rise and sharp fall group.
Conclusion The risk of bladder cancer did not show much difference according to trajectories, except for low steady group. 
Thus quitting smoking should be the priority to lower the risk of bladder cancer in smokers.
Keywords Smoking · Trajectory · Bladder cancer · Young adults
Introduction
While bladder cancer is a relatively rare cancer in Korea, 
globally the incidence is gradually increasing and has 
been reported to have a poor prognosis. In previous stud-
ies, several risk factors were identified for early diagnosis 
or prevention of this type of cancer. Smoking [1], coffee 
consumption [2, 3], occupational exposure [4], and dietary 
factors [5] constitute the most important exogenous risk fac-
tors for bladder carcinogenesis [6]. Among these, smoking 
is the most well-known risk factor for bladder cancer [7, 8].
A meta-analysis of the association between smoking and 
bladder cancer in 89 observational studies showed that the 
summary odds ratio of bladder cancer incidence was 3.14 
times (2.53–3.75) in current smokers and 1.83 (1.52–2.14) 
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times in former smokers [9]. Moreover, it has been reported 
that second-hand smoking increases the risk of bladder can-
cer in non-smokers [10].
Association between coffee consumption and bladder 
cancer remains controversial.
Case–control study conducted by Yu et al. reported the 
positive association between coffee consumption and blad-
der cancer among never smokers but not in current smok-
ers [3]. Meta-analysis published by Dai et al. reported that 
to date available evidence was insufficient to support an 
independent association between coffee consumption and 
bladder cancer risk [2]. Although, there was an increased 
risk of bladder cancer related to higher coffee consumption 
among studies with fewer cases (RR high vs low = 1.38, 95% 
CI 1.05–1.81), smoking was poorly adjusted among these 
studies.
The previous studies have the following characteristics. 
First, they were mostly case–control studies with some 
exceptions [11]. Second, many studies have examined the 
association with bladder cancer by measuring smoking once 
at the baseline. However, smoking pattern has the charac-
teristic of changing over time, especially in young adults 
[12]. Third, the study subjects were mostly middle-aged and 
elderly. However, in fact, a rapid increase in the smoking rate 
is observed in young people in their 20s and 30s [13, 14].
Therefore, it is meaningful to investigate the high rate of 
smoking in young people and the risk of developing bladder 
cancer in the middle-aged population. In particular, reports 
on the long-term health effects according to the pattern of 
smoking behavior examined multiple times in young indi-
viduals are rare. Moreover, the effect of repeatedly meas-
ured smoking status analyzed by group-based trajectory on 
bladder cancer remains uncertain. Therefore, our aim was to 
analyze the trajectory of smoking in young adults and ana-
lyze the bladder cancer incidence in each trajectory group.
Methods
Study population
This study is part of the Korean Life Course Health Study 
(KLCHS), which has been described previously [15]. The 
study population was selected from the national health 
examination conducted on a biennial basis for Korean civil 
and private school staff since 1992. From 1992 to 1999, 
health examination by Korea medical insurance corpora-
tion (KMIC) was provided in even years to insured per-
sons and in odd years to dependents. A total of 4,862,438 
(10.7%) members of the Korean population were cov-
ered by KMIC insurance; among them, 1,297,833 were 
employees and 3,364,405 were dependents. Since 2000, 
coverage for even-numbered and odd-year births have been 
provided health examination by National Health Insurance 
Service (NHIS).
Even-numbered and odd-year births have been provided 
health examination by National Health Insurance Service 
(NHIS). The characteristics of this study can be found in 
the previously reported Korean Cancer Prevention Study 
(KCPS) [14, 15]
For this study, 430,951 individuals (307,652 males, 
123,299 females) aged 20–39 years were selected based 
on their ages in 1992 and 1993. Among them, the smoking 
rate in women was extremely low (0.2%), and they were 
excluded. Of the 307,652 men, 298,440 were included in 
the study at baseline, with the exception of 9,212, who 
were missing in the 1992–1993 survey. The following 
two-year screenings included 274,978 in 1994–1995; 
252,209 in 1996–1997; 231,829 in 1998–1999; 197,006 
in 2000–2001; 177,467 in 2002–2003; and 161,098 per-
sons in 2004–2005. Of the 161,098 participants, 29 were 
excluded for having already developed cancer, so the 
final sample was 161,069 men. The study proposal was 
approved by the Institutional Review Board of Human 
Research, Yonsei University (4-2001-0029).
Smoking behavior and other covariate data
All participants were given the opportunity to undergo 
a medical examination every two years since 1992. The 
smoking history data were obtained by a self-administered 
questionnaire. Cigarette smoking history was coded from 1 
to 5. The smoking variables in this study were divided into 
five groups as follows: 1 = non-smokers, 2 = ex-smokers, 
3 = 1–9 cigarettes per day, 4 = 10–19 cigarettes per day, 
and 5 = more than 20 cigarettes per day. This analysis was 
performed assuming an interval variable. These surveys 
on smoking amount were conducted every two years from 
1992 to 2005. Height, weight, alcohol intake, and exercise 
habit of all participants were recorded to describe the char-
acteristics of the participants. Height, weight and alcohol 
intake were recorded by professionally trained investigator. 
Information on exercise was obtained by asking “Do you 
exercise regularly?” (Yes/No). If participants answered 
“Yes,” they were asked to indicate the frequency of exer-
cise per week on continuous scale. In this study, we merely 
used dichotomous variable.
Bladder cancer follow-up
The occurrence of bladder cancer was tracked from 
2006 to 2016. Bladder cancer (ICD-10 code C67) was 
confirmed through the National Cancer Registry of the 
Korean National Cancer Center.
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Statistical analysis
Our study analyzed the smoking pattern in 161,069 young 
people aged 20–39 years through the trajectory analysis of 
smoking, measured seven times over 14 years from 1992 
to 2005. Trajectory analyses were performed using seven 
repeated surveys of cigarette per day, using the PROC TRAJ 
command in SAS [17, 18]. PROC TRAJ is a SAS Trajec-
tory for group-based modeling of longitudinal data (SAS 
Institute, Inc., Cary, NC, USA)
Trajectory analysis uses semi parametric group-based 
modeling strategies to identify potential patterns of end-to-
end data. Each model represents an individual with a similar 
trajectory [18]. Using Bayesian Information Criterion (BIC) 
to assess the best model fit, number of trajectory groups 
were limited to less than six [19, 20]. We grouped the name 
according to the characteristics of the five trajectory groups 
shown in Fig. 1 as follows: Group 1 (29.0%), ‘low steady’ 
refers to the participants who were maintained low smok-
ing amount; Group 2 (18.1%), ‘lowering’ refers to partici-
pants who steadily reduced their smoking amount; Group 
3 (4.4%), ‘high steady’ refers to participants who showed 
steadily rising smoking amount; Group 4 (24.7%), ‘rise and 
sharp fall’ refers to participants who initially had high smok-
ing amount and showed sharped decreased after the 4-year 
follow-up.
Group 5 (16.1%), ‘rise and fall’ refers to participants who 
initially increased their smoking amount and decreased later; 
Group 6 (7.7%), ‘very high steady’ refers to those who kept 
on maintaining high smoking amount.
The association between smoking history and bladder 
cancer was analyzed in three models. We compared Model 
1 and Model 2 to clarify the risk of bladder cancer according 
to the smoking status in the baseline period (Model 1) and 
the smoking status in the intermediate period (Model 2). 
Model 1 analyzed bladder cancer incidence according to the 
amount of smoking in 1992–1993. Model 2 analyzed blad-
der cancer incidence according to the amount of smoking 
in 2004–2005. Model 3 analyzed bladder cancer incidence 
according to the group finally adopted in trajectory analy-
sis during 1992–2005. Various models, including smoking 
measured once and smoking trajectory, were evaluated as 
Akaike information criteria (AIC) values. Time depend-
ent analysis was performed in consideration of lag time in 
Model 4. The relative risk of smoking was analyzed by the 
Cox proportional hazard model including age, body mass 
index (BMI), and alcohol consumption. Statistical analysis 
was performed using SAS 9.4.
Results
Table  1 compares the general characteristics of the 
161,069 participants included in the final analysis of 
this study with the 146,583 participants not included. 
The mean age, BMI, and alcohol consumption of the two 
groups were statistically different. Also, the overall dis-
tribution of smoking amount showed similar trends but 
were statistically different; exercise, in contrast, showed no 
difference. Among the 161,069 participants, the average 
Fig. 1  Trajectory group of 
smoking amounts in Korean 
young adult men
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age (standard deviation) was 34.0 (3.9) years. Participants 
were observed for 2,280,143 person-years during the aver-
age follow-up period of 14.2 (median 14.3) years. During 
this period, 263 new cases of bladder cancer (incidence 
11.5/100,000 PY) occurred. By age group, there were 13 
cases in 20–29 year olds (7.7/100,000 PY), 71 cases in 
30–39 year olds (7.3/100,000 PY), and 179 cases in 40–49 
year olds (16.3/100,000 PY). During the follow-up period, 
total deaths were 3,461, of which 23 were due to bladder 
cancer.
Table 2 shows the general characteristics of the six trajec-
tory groups (low steady, lowering, rise and fall, high steady, 
rise and sharp fall, and very high steady) from the smok-
ing amount record measured every two years from 1992 to 
2005 (bottom and right in Fig. 1). In the ‘low steady’ group, 
which had a lower smoking rate, 66.9% were non-smokers in 
1992–1993 and 30.1% were ex-smokers. In 2004–2005, most 
of them were reported as non-smokers, with a non-smoking 
rate was 91.8%. In contrast, the ‘very high steady’ group 
had a very low non-smoking rate in 1992–1993 (0.3%), and 
82.7% of the groups smoked more than 20 cigarettes per day. 
In 2004–2005, 71.5% of the respondents smoked more than 
20 cigarettes per day.
There were two groups with high smoking rates and then 
sudden declines. First, ‘the rise and fall’ group had a high 
smoking rate in 1992–1993, with 17.2% of those in 20 or 
more and 0% in 20 or more in 2004–2005. The ‘rise and 
sharp fall’ group, in contrast, was already high at 83.8% 
in 1992–1993 and dropped sharply to 0.3% in 2004–2005.
Table 1  General characteristics of the groups included and not 
included in the study at baseline (1992–1993)
Included Excluded p value
N 161,069 146,583
Mean age, years (SE) 34.0 (3.9) 33.5 (4.2)  < 0.0001
Body mass index, kg/m2 (SE) 23.0 (2.5) 23.1 (2.5)  < 0.0001
Alcohol intake, g per day (SE) 17.2 (20.7) 19.0 (23.9)  < 0.0001
Smoking amount, cigs. per day




 20 + 18.0% 20.2%
Exercise
 No 1 79.9% 79.9% 0.6880
 Yes 2 20.1% 20.1%
Table 2  General characteristics by trajectory group based on the smoking amount recorded every two years from 1992 to 2005
Low steady Lowering Rise and fall High steady Rise and sharp fall Very high steady
N (%) 46,756 (29.0) 29,101 (18.1) 25,969 (16.1) 39,741 (24.7) 7,100 (4.4) 12,402 (7.7)
Age, mean (SD), years 34.1 (4.0) 34.3 (3.9) 34.0 (3.9) 33.7 (4.0) 34.3 (3.9) 33.9 (4.0)
Weight, kg (SD) 66.2 (8.0) 66.8 (8.0) 66.9 (8.2) 66.4 (8.2) 66.9 (8.5) 68.2 (8.5)
Height, cm (SD) 169.8 (4.9) 170.4 (4.9) 170.4 (4.9) 170.3 (4.9) 170.6 (4.8) 170.5 (4.8)
Body mass index, kg/m2 (SD) 22.9 (2.4) 23.0 (2.4) 23.0 (2.4) 22.9 (2.4) 23.5 (2.5) 23.4 (2.5)
Alcohol amount, cig/day (SD) 11.0 (15.9) 16.8 (19.3) 19.2 (21.0) 19.6 (20.9) 24.4 (26.1) 25.5 (27.2)
Smoking in 1992–1993, N (%)
 Non 31,297 (66.9) 536 (1.8) 190 (0.7) 508 (1.3) 4 (0.1) 29 (0.3)
 Ex 14,074 (30.1) 9,817 (33.7) 1,305 (5.0) 1,590 (4.0) 35 (0.5) 70 (0.6)
 1–9 1,200 (2.6) 11,410 (39.2) 6,162 (23.8) 8,109 (20.4) 70 (1.0) 216 (1.7)
 10–19 147 (0.3) 5,743 (19.7) 13,846 (53.3) 22,857 (57.5) 1,039 (14.6) 1,829 (14.8)
 20 + 38 (0.1) 1,595 (5.5) 4,466 (17.2) 6,677 (16.8) 5,952 (83.8) 10,258 (82.7)
Smoking in 1998–1999, N (%)
 Non 41,819 (89.4) 5,188 (17.9) 533 (2.1) 897 (2.3) 25 (0.3) 59 (0.5)
 Ex 4,477 (9.6) 13,044 (44.8) 2,499 (9.6) 1,566 (3.9) 52 (0.7) 86 (0.7)
 1–9 367 (0.8) 8,385 (28.8) 2,740 (10.6) 2,482 (6.3) 24 (0.3) 30 (0.2)
 10–19 74 (0.2) 2,357 (8.1) 17,451 (67.2) 28,572 (71.9) 1,235 (17.4) 1,364 (11.0)
 20 + 19 (0.04) 127 (0.4) 2,746 (10.6) 6,224 (15.7) 5,766 (81.2) 10,866 (87.6)
Smoking in 2004–2005, N (%)
 Non 42,927 (91.8) 9,399 (32.3) 9,592 (36.9) 114 (0.3) 2,513 (35.4) 0 (0.0)
 Ex 3,093 (6.6) 13,826 (47.5) 13,458 (51.8) 1,218 (3.1) 3,434 (48.4) 0 (0.0)
 1–9 602 (1.3) 4,617 (15.9) 2,559 (9.9) 4,336 (10.9) 336 (4.7) 129 (1.0)
 10–19 112 (0.2) 1,177 (4.0) 365 (1.4) 29,287 (73.7) 799 (11.3) 3,406 (27.5)
 20 + 22 (0.1) 82 (0.3) 0 (0.0) 4,786 (12.0) 18 (0.3) 8,867 (71.5)
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Table 3 shows the association between smoking and blad-
der cancer in the four models. Model 1 shows the association 
between smoking status in 1992–1993 and bladder cancer. 
We made an examination using different smoking status 
period in Model 2 analyzing the association between smok-
ing status in 2004–2005 and bladder cancer.
Model 3 compared the association of bladder cancer 
with the trajectory group based on the smoking amount at 
7 time-points in 1992–2005. Since the smoking status was 
measured in 1992–1993, the hazard ratio (95% confidence 
interval [CI]) of bladder cancer in the ex-smokers compared 
to non-smokers was 1.08 (0.65 to 1.79), which was not sig-
nificant. However, in 1992–1993, when the amount of smok-
ing was 1–9 cig per day, the hazard ratio (95% CI) of bladder 
cancer was 2.36 (1.53 to 3.64), 2.17 (1.53 to 3.64) for 10–19 
cig per day, and 2.54 (1.69 to 3.84) for more than 20 cigs per 
day, which were all significant.
Model 2 analyzes the association between the smok-
ing amount in 2004–2005 and the risk of bladder cancer 
during 2005–2016. Compared to non-smokers, ex-smokers 
were 1.40 times more likely to develop bladder cancer. In 
addition, current smokers with 10–19 cig per day were 
1.67 times more likely to develop bladder cancer.
Model 3 (AIC = 6472.382), which analyzed the asso-
ciation between the trajectory group of smoking amount 
and bladder cancer incidence, showed better performance 
than did model 2 (AIC = 6485.267). Among the six trajec-
tory groups, there was a higher risk of developing bladder 
cancer in the other groups compared to the ‘low steady’ 
group. The highest risk group was ‘very high steady’ 
group with a hazard ratio = 2.76 (1.77 to 4.31). In addi-
tion, the risk of bladder cancer was 2.52 (95% CI 1.50 to 
4.23) in the rise and sharp fall group.
Model 4 shows the time varying effect of smoking on 
bladder cancer, the performance was better than the trajec-
tory model (AIC = 6472.382). Time varying current smok-
ing raised the risk of bladder cancer by 2.50 (95% CI 1.73 
to 3.61) times higher than non-smoking.
Table 3  Smoking and bladder cancer risk in three models (Cox proportional hazard model)
*Adjusted for age, body mass index, and alcohol amount; Participants (n = 85) with missing records on smoking amount were excluded
AIC Difference between model 3 and model 4 was 24.436 (p value < 0.001)
Classic approach Trajectory approach Time dependent analysis
Model 1 Model 2 Model 3 Model 4
Smoking in 1992–1993
 Non 1.0
 Ex 1.08 (0.65 to 1.79)
 1–9 2.36 (1.53 to 3.64)
 10–19 2.17 (1.45 to 3.25)
 20 + 2.54 (1.69 to 3.84)
Smoking in 2004–2005
 Non 1.0
 Ex 1.40 (1.02 to 1.93)
 1–9 1.28 (0.80 to 2.04)
 10–19 1.67 (1.39 to 2.51)
 20 + 1.43 (0.91 to 2.24)
Trajectory in 1992–2005
 Low steady 1.0
 Lowering 1.59 (1.06 to 2.38)
 Rise and fall 1.40 (1.34 to 2.97)
 High steady 2.21 (1.55 to 3.15)
 Rise and sharp fall 2.52 (1.50 to 4.23)
 Very high steady 2.76 (1.77 to 4.31)
Time varying smoking
 Non 1.0
 Current smoking 2.50 (1.73 to 3.61)
 Bladder cancer/N 294/161,064 294/161,064 294/161,064 281/161,051
 Degree of freedom 7 7 8 4
 Akaike’s Information Criteria 6564.443 6485.267 6472.382 6447.946
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Discussion
Through trajectory analysis, our study analyzed the pat-
terns of the smoking amount measured 7 times during 
14  years for people aged 20–39  years, in whom high 
smoking prevalence is observed during their lifetime. We 
also analyzed the relationship between trajectory group 
and bladder cancer. As a result, the groups with the high-
est smoking amounts (high steady and very high steady) 
showed more than twice the risk of bladder cancer. Fur-
ther, the rise and fall and the rise and sharp fall groups still 
showed more than double the risk.
Our results were similar to the results of the meta-anal-
ysis reported in 2018 [1, 9]. In the meta-analysis, current 
smokers showed 3.14 times higher risk than non-smokers, 
while the risk of very high steady group was 2.83 higher 
in our study. The conclusion of the meta-analysis was that 
active smokers are at an increased risk of bladder cancer.
“However, due to heterogeneity between the population 
used in our study and population of studies involved in the 
meta-analysis, we should conduct cautious interpretation 
to compare the results in two studies. While the studies 
involved in the meta-analysis analyzed the risk of bladder 
cancer in age 70s, participants used in our study was rela-
tively young, therefore we were allowed to analyze the risk 
of bladder cancer when the participants became middle-
aged.” Dose–response meta-analyses showed a bladder 
cancer risk plateau for smoking intensity; this indicates 
that even after long-term smoking cessation, the risk of 
bladder cancer remains high [1, 9] In the meta-analysis, 
the risk of bladder cancer of the group that quit smoking 
was 1.83 times higher risk compared with never smokers. 
In our study, the risk of the group that continued to show 
a high smoking rate but later abruptly quit was 1.94 to 
2.61 times higher. However, during the smoking history 
period, the lowering group, in which individuals continued 
to reduce the smoking amount from the beginning, did not 
show a significantly increased bladder cancer risk (hazard 
ratio, 1.50, 95% CI 0.98 to 2.30).
The trajectory analysis in this study is also different 
from other reports, in which the smoking cessation group 
was subdivided into three heterogeneous groups to ana-
lyze the effects of bladder cancer. This study used both a 
classic epidemiologic study approach and a group-based 
trajectory approach for smoking and bladder cancer. In 
other words, the analysis between 2006 and 2016 accord-
ing to the smoking amount in 1992–1993 (model 1 in 
Table 3) and the analysis between 2006 and 2016 accord-
ing to smoking history in 2004–2005 (model 2 in Table 3) 
were the analyses of the classic approach. Model 1 and 
Model 2 could not directly compare the AIC values for 
performance because the number of subjects included in 
the analysis was different. However, comparing model 2 
with the trajectory model 3, the performance of model 3 
was significantly better.
Smoking and other lifestyle factors are the most impor-
tant exogenous risk factors for bladder cancer. However, 
individuals with seemingly equal exposure to environmen-
tal risk factors develop bladder cancer in a heterogeneous 
pattern. This is probably attributed to the fact that genetic 
background varies in human populations, pointing to the 
role of genetic susceptibility in human cancer [6]. Smoking 
accounts for approximately 52% of the bladder cancer inci-
dence among postmenopausal women, but the underlying 
mechanism is poorly understood. There is a recent study 
on whether DNA methylation levels in the blood predict 
the development of bladder cancer [6, 16]. They suggested 
that differential methylation of cg05575921 and cg19859270 
mediate the effects of smoking on bladder cancer, poten-
tially revealing downstream effects of smoking relevant for 
carcinogenesis.
In the present study, since the trajectory analysis included 
only those subjects with all seven results, whose smoking 
history was examined from 1992 to 2004, it was important 
to compare the general characteristics of these differences 
(Table 1). In both groups, there were statistically significant 
differences in age, BMI, alcohol consumption, and smoking, 
but the overall mean and distributions were similar. This can 
be observed as the statistical significance due to the large 
sample. Thus, although it may be interpreted that there was a 
slight selection bias in the entire population, it did not seem 
to have a significant effect on the study results.
The strength of this study was that trajectory groups were 
formed using seven repeatedly measured smoking data over 
a 12-year period. However, while such a long follow-up 
time was an advantage [17, 18], there was a limitation in 
that those who did not participate in every survey had to 
be excluded because the amount of smoking was missing. 
Another limitation was that smoking data were measured as 
interval variables rather than continuous variables. Despite 
these limitations, the overall result is considered to be justi-
fied in the high risk of bladder cancer in the group that con-
tinued to maintain high levels of smoking amounts. Another 
limitation was that the study did not include variables for 
fluid intake and socio-economical status in multivariate 
analysis.
This study analyzed only males because smoking rates 
among females were very low.
Recently, the risk of smoking has been observed to be 
high in women with bladder cancer, and the interaction 
between smoking and sex has been reported [21]. There-
fore, a sex interaction study on bladder cancer would be an 
important topic for future studies.
In conclusion, the smoking status measured at the base-
line may change over time. With this in mind, analyzing 
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trajectory provides information on important implications 
for understanding health-related concerns throughout life. 
Those who maintained high steady smoking had a higher 
risk of developing bladder cancer. Quitting smoking, or 
reducing the smoking amount, can be effective in reducing 
the risk of bladder cancer.
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